Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
between 1 and 18
years old
The phase for this study is not defined.
Show me locations

The purpose

This open-label, multi-center study is open to patients 1 to 18 years of age at time of enrollment with medication resistant epilepsy.

Provided treatments

  • Drug: Cannabidiol (Epidiolex)
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT02397863. The sponsor of the trial is Augusta University and it is looking for 0 volunteers for the current phase.
Official trial title:
An Open Label, Multi-Center Study to Investigate the Safety of Cannabinoid (GWP42003-P) in Children With Medication Resistant Epilepsy